000 04546nam a22005895i 4500
001 978-3-031-65650-7
003 DE-He213
005 20251030113320.0
007 cr nn 008mamaa
008 241120s2024 sz | s |||| 0|eng d
020 _a9783031656507
_9978-3-031-65650-7
024 7 _a10.1007/978-3-031-65650-7
_2doi
050 4 _aRC799-869
072 7 _aMNG
_2bicssc
072 7 _aMED031000
_2bisacsh
072 7 _aMNG
_2thema
245 1 0 _aDysbiosis
_h[electronic resource] :
_bCorrelation between Changes in Microbiota and Pathology /
_cedited by Jaime Ruiz-Tovar.
250 _a1st ed. 2024.
264 1 _aCham :
_bSpringer Nature Switzerland :
_bImprint: Springer,
_c2024.
300 _aV, 144 p. 13 illus. in color.
_bonline resource.
336 _atext
_btxt
_2rdacontent
337 _acomputer
_bc
_2rdamedia
338 _aonline resource
_bcr
_2rdacarrier
347 _atext file
_bPDF
_2rda
505 0 _aMicrobiota, Microbiome,Applied technologies and omics techniques applied to the microbiota. Metagenomics -- Use of Probiotics, Prebiotics, Symbiotics,Postbiotics,Nutrition and microbiota -- Microbiota and neurodegenerative and brain diseases -- Microbiota and diseases associated with the digestive system.-Microbiota and diseases associated with rheumatic and autoimmune diseases -- Microbiota and diseases associated with metabolic syndrome -- Microbiota and diseases associated with the cardiovascular system -- Microbiota and gynaecological diseases -- Microbiota and cancer -- Microbiota and dermatological diseases -- Microbiota in Neonatology and Paediatrics -- Microbiota and diseases associated with ageing.
520 _aThis book discusses in detail the pathological aspects associated with alterations in the gut microbiota and the pathogenesis of different disorders related to dysbiosis. The volume describes the impact of dysbiosis on organs other than the gut and brain, such as metabolic diseases, cancer, gynecologic disorders, aging, or pediatric pathologies. Additionally, it associates the mechanisms and metabolic signaling pathways related to gut microbiota homeostasis and alterations with their clinical impact, highlighting the importance of translational research on dysbiosis. The volume is divided into 12 chapters: the first two chapters present diagnostic methods and therapeutic options, including prebiotics and probiotics. The remaining ten chapters specifically focus on diseases of different organs. Moreover, the relevance of these findings to precision medicine will be discussed. The book provides biomedical professionals, basic researchers, and clinical practitioners, especially those specialized in Precision Medicine and Integrative Medicine, with information about the effects of dysbiosis on the physiopathology of various diseases. It also includes updated evidence on the impact of dysbiosis on numerous pathologies, such as metabolic diseases, cancer, gynecologic disorders, aging, or pediatric pathologies, going beyond gastrointestinal and central nervous system diseases typically covered in many publications. Furthermore, the book addresses the translational aspect of dysbiosis. It starts with the basic research knowledge on dysbiosis and disease and aims to provide a translational approach applicable to clinical practice. By combining the fundamental knowledge of biomedical researchers with the clinical applicability of healthcare practitioners, this book bridges the gap between theory and practice.
650 0 _aGastroenterology.
_976519
650 0 _aMetabolism
_xDisorders.
_978415
650 0 _aOncology.
_970760
650 0 _aGynecology .
_964086
650 0 _aGeriatrics.
_964200
650 0 _aPediatrics.
_964087
650 1 4 _aGastroenterology.
_976519
650 2 4 _aMetabolic Disease.
_978417
650 2 4 _aOncology.
_970760
650 2 4 _aGynecology.
_964086
650 2 4 _aGeriatrics.
_964200
650 2 4 _aPediatrics.
_964087
700 1 _aRuiz-Tovar, Jaime.
_eeditor.
_4edt
_4http://id.loc.gov/vocabulary/relators/edt
_987759
710 2 _aSpringerLink (Online service)
773 0 _tSpringer Nature eBook
776 0 8 _iPrinted edition:
_z9783031656491
776 0 8 _iPrinted edition:
_z9783031656514
776 0 8 _iPrinted edition:
_z9783031656521
856 4 0 _uhttps://doi.org/10.1007/978-3-031-65650-7
912 _aZDB-2-SME
912 _aZDB-2-SXM
999 _c65072
_d65072